The companies' shared goal was to help vulnerable areas by giving out immunizations.
In order to provide immunizations in places with a clear need between 2021 and 2022, Remote Medical International (RMI), a firm that specialises in preserving the health of workers in various parts of the world, teamed up with healthcare solutions provider Acacium Group.
During the pandemic, their shared goal was to distribute mobile vaccine and COVID-19 test processing machines throughout the UK's Midlands and South East.
The businesses processed more than 200,000 tests throughout the duration of their implementation and provided mobile testing with results in less than three hours. Additionally, the project required the administration of 3000 immunizations, 40% of which were given to those who were most in need, including the immunocompromised, the housebound, the homeless, and populations who had previously disengaged from the government's vaccination programme.
Leicestershire, Nottinghamshire, Shropshire, the West Midlands, East Sussex, Kent, Berkshire, Hertfordshire, Worcestershire, and West Essex were among the specific regions targeted.
The roll-out was prompted by the UK's growing need for COVID-19 testing and processing services, especially in remote locations where temporary clinics were difficult to set up. RMI oversaw the management of 15 vans and 15 trailers that were stationed in a variety of UK localities, including rural areas, areas with a high elderly population, and regions where the government booking system was not widely used.
The vans and trailers were fitted as either mobile processing units or mobile vaccination units, performing two distinct tasks.
The UK Health Security Agency also requested the service to protect the health of VIPs and foreign ministers present at the G7 Foreign and Development Ministers' meeting, which took place in Liverpool in December 2021. The service was in high demand throughout the previous year.
"Through our relationship with the Acacium Group, we were able to support the enormous efforts of our National Health Service in both the delivery of vaccines and the processing of COVID-19 tests," stated Jules Rawles, managing director, UK at RMI. In order to improve access to care and utilise the distinctive skill sets of RMI medics, we operated mobile units that transported essential health services to the communities that needed them most.
The wider public healthcare system will continue to have access to this rapid approach to solution deployment in the coming years.
World BI Group examines how research like this could affect drug clinical trials and innovation and all the challenges that come along with it. This year's 19th Clinical Trials Innovation Programmes and 20th Clinical Trials Innovation Programmes will highlight the future of clinical trials and drug development post-COVID and will feature tailored sessions presented by the leading experts from across the globe, so if you’re someone interested in the pharmaceutical industry, we encourage you to attend the 19th Clinical Trials Innovation Programmes and 20th Clinical Trials Innovation Programmes, which are prominent platforms for interacting with the world's most influential and dynamic professionals. With the 19th Clinical Trials Innovation Programmes and 20th Clinical Trials Innovation Programmes, learn how modernization in R&D processes is fundamentally changing what clinical trial research will look like in the next two to five years. So, join us in October 2022 for an in-person experience and two days of top-level strategic content and current scientific insights, networking, and discussions with top global pharmaceutical R&D executives. We are bringing together the best in the industry to help you learn, grow, and accelerate your drug development journey. This event will give you a chance to attend and get a complete learning experience about the challenges and their solutions from experts in the field. Register here to meet new clients, build your brand, get a handle on the market and drive new business.